Patrick Machado : Appointed to Axovant Board of Directors
Patrick Machado ‘86, has recently joined the Board of Directors for Axovant Sciences, a biopharmaceutical company focused on developing commercialized medicines for neurological disorders.
"I am delighted to welcome Pat to our board," said David Hung in a press release, M.D., Chief Executive Officer of Axovant Sciences. "We believe Pat's deep business development experience and his insights will help position Axovant to become the leading company in neurology in the years to come.
"I am thrilled to join this group of esteemed directors and help guide Axovant into the future," said Mr. Machado in a recent press release. "I am excited to be part of an organization focused on such important work and I look forward to contributing to the impact that this company could have on millions of patients around the world."
Read the full press release »